FrontPoint health-care funds reportedly shutting

Bloomberg News says $1.5 billion hedge funds are closing down after allegations a manager got inside tips on a Human Genome Sciences drug trial. A spokesman for FrontPoint declines to comment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.